{
  "symbol": "CVS",
  "year": 2023,
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.2529,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.29
  },
  "top_positive": [
    {
      "sent": "monetary policy, can significantly and adversely affect the value of our investment portfolio, our operating results and/or our financial condition by: \u2022 significantly reducing the value and/or liquidity of the debt securities we hold in our investment portfolio and creating realized capital losses that reduce our operating results and/or unrealized capital losses that reduce our shareholders\u2019 equity; \u2022 lowering interest rates on high-quality short-term or medium-term debt securities and thereby materially reducing our net investment income and operating results as the proceeds from securities in our investment portfolio that mature or are otherwise disposed of continue to be reinvested in lower yielding securities; \u2022 reducing the fair values of our investments if interest rates rise; \u2022 causing non-performance of or defaults on their obligations to us by third parties, including customers, issuers of securities in our investment portfolio, mortgage borrowers and/or reinsurance and/or derivatives counterparties; \u2022 making it more difficult to value certain of our investment securities, for example if trading becomes less frequent, which could lead to significant period-to-period changes in our estimates of the fair values of those securities and cause period-to-period volatility in our net income and shareholders\u2019 equity; \u2022 reducing our ability to issue short-term debt securities at attractive interest rates, thereby increasing our interest expense and decreasing our operating results; and \u2022 reducing our ability to issue other securities.",
      "score": 0.9902
    },
    {
      "sent": "monetary policy, can significantly and adversely affect the value of our investment portfolio, our operating results and/or our financial condition by: \u2022 significantly reducing the value and/or liquidity of the debt securities we hold in our investment portfolio and creating realized capital losses that reduce our operating results and/or unrealized capital losses that reduce our shareholders\u2019 equity; \u2022 lowering interest rates on high-quality short-term or medium-term debt securities and thereby materially reducing our net investment income and operating results as the proceeds from securities in our investment portfolio that mature or are otherwise disposed of continue to be reinvested in lower yielding securities; \u2022 reducing the fair values of our investments if interest rates rise; \u2022 causing non-performance of or defaults on their obligations to us by third parties, including customers, issuers of securities in our investment portfolio, mortgage borrowers and/or reinsurance and/or derivatives counterparties; \u2022 making it more difficult to value certain of our investment securities, for example if trading becomes less frequent, which could lead to significant period-to-period changes in our estimates of the fair values of those securities and cause period-to-period volatility in our net income and shareholders\u2019 equity; \u2022 reducing our ability to issue short-term debt securities at attractive interest rates, thereby increasing our interest expen\nadditional capital, subject to market conditions.",
      "score": 0.9881
    },
    {
      "sent": "A number of factors contribute to rising health care and other benefit costs, including COVID-19 or other variants or viruses, previously uninsured members entering the health care system, changes in members\u2019 behavior and health care utilization patterns, turnover in our membership, additional government mandated benefits or other regulatory changes (including under the Families First Act, the CARES Act, and the American Rescue Plan Act), changes in the health status of our members, the aging of the population and other changing demographic characteristics, advances in medical technology, increases in the number and cost of prescription drugs (including specialty pharmacy drugs and ultra-high cost drugs and therapies), direct-to-consumer marketing by drug manufacturers, the increasing influence of social media on our members\u2019 health care utilization and other behaviors, changes in health care practices and general economic conditions (such as inflation and employment levels).",
      "score": 0.9822
    }
  ],
  "top_negative": [
    {
      "sent": "We and our vendors are subject to business continuity hazards and other risks, including natural disasters, utility and other mechanical failures, acts of war or terrorism, acts of civil unrest, crime, disruption of communications, data security and preservation, disruption of supply or distribution, safety regulation and labor difficulties.",
      "score": -0.9648
    },
    {
      "sent": "We and our vendors are subject to business continuity hazards and other risks, including natural disasters, utility and other mechanical failures, acts of war or terrorism, acts of civil unrest, crime, disruption of communications, data security and preservation, disruption of supply or distribution, safety regulation and labor difficulties.",
      "score": -0.9648
    },
    {
      "sent": "Companies involved in public health care programs such as Medicare and/or Medicaid are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits.",
      "score": -0.9607
    }
  ],
  "forward_snippets": [
    "This information includes, but is not limited to: \u201cOutlook for 2023\u201d of Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations (\u201cMD&A\u201d) included in Item 7, \u201cQuantitative and Qualitative Disclosures About Market Risk\u201d included in Item 7A, \u201cGovernment Regulation\u201d included in Item 1, and \u201cRisk Factors\u201d included in Item 1A.",
    "In addition, throughout this 10-K and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements: \u00b7 Anticipates \u00b7 Believes \u00b7 Can \u00b7 Continue \u00b7 Could \u00b7 Estimates \u00b7 Evaluate \u00b7 Expects \u00b7 Explore \u00b7 Forecast \u00b7 Guidance \u00b7 Intends \u00b7 Likely \u00b7 May \u00b7 Might \u00b7 Outlook \u00b7 Plans \u00b7 Potential \u00b7 Predict \u00b7 Probable \u00b7 Projects \u00b7 Seeks \u00b7 Should \u00b7 View \u00b7 Will All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the impact of coronavirus disease 2019 (\u201cCOVID-19\u201d) and any new variants or viruses on the Company\u2019s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, statements related to possible, proposed or pending acquisitions, joint ventures, investments or combinations that involve, among other things, the timing or likelihood of receipt of regulatory approvals, the timing of completion, integration synergies, net synergies and integration risks and other costs, including those related to CVS Health\u2019s proposed acquisition of Oak Street Health, Inc.",
    "This information includes, but is not limited to: \u201cOutlook for 2023\u201d of Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations (\u201cMD&A\u201d) included in Item 7, \u201cQuantitative and Qualitative Disclosures About Market Risk\u201d included in Item 7A, \u201cGovernment Regulation\u201d included in Item 1, and \u201cRisk Factors\u201d included in Item 1A.",
    "In addition, throughout this 10-K and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements: \u00b7 Anticipates \u00b7 Believes \u00b7 Can \u00b7 Continue \u00b7 Could \u00b7 Estimates \u00b7 Evaluate \u00b7 Expects \u00b7 Explore \u00b7 Forecast \u00b7 Guidance \u00b7 Intends \u00b7 Likely \u00b7 May \u00b7 Might \u00b7 Outlook \u00b7 Plans \u00b7 Potential \u00b7 Predict \u00b7 Probable \u00b7 Projects \u00b7 Seeks \u00b7 Should \u00b7 View \u00b7 Will All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the impact of coronavirus disease 2019 (\u201cCOVID-19\u201d) and any new variants or viruses on the Company\u2019s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, statements related to possible, proposed or pending acquisitions, joint ventures, investments or combinations that involve, among other things, the timing or likelihood of receipt of regulatory approvals, the timing of completion, integration synergies, net synergies and integration risks and other costs, including those related to CVS Health\u2019s proposed acquisition of Oak Street Health, Inc.",
    "This information includes, but is not limited to: \u201cOutlook for 2023\u201d of Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations (\u201cMD&A\u201d) included in Item 7, \u201cQuantitative and Qualitative Disclosures About Market Risk\u201d included in Item 7A, \u201cGovernment Regulation\u201d included in Item 1, and \u201cRisk Factors\u201d included in Item 1A."
  ]
}